Appeal No. 1997-2167
Application 08/137,444
inhibitor 6-O-demethylgalanthamine.
While we agree with the examiner's conclusion that claims
50 and 51 are not models of clarity, we find the claims
adequately define the metes and bounds of what appellants
intend to claim by the claim language. We find the claims are
directed to administering the compounds of either claim 2 or
31, respectively, for the purpose of being converted in situ
in the mammal to whom the compounds are administered to the
known AChE inhibitor 6-O-demethylgalanthamine. Accordingly,
the rejection is reversed.
SUMMARY
The rejection of claims 1 through 52 under 35 U.S.C. §
112, first paragraph, is reversed. The rejection of claims 1
through 4 under 35 U.S.C. § 112, first paragraph, is reversed.
The rejection of claims 50 and 51 under 35 U.S.C. § 112,
second paragraph, is reversed.
The decision of the examiner is reversed.
REVERSED.
22
Page: Previous 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next
Last modified: November 3, 2007